Download
12876_2024_Article_3429.pdf 1,42MB
WeightNameValue
1000 Titel
  • Biliary drainage in palliative and curative intent European patients with hilar cholangiocarcinoma and malignant hilar obstruction: a retrospective single center analysis
1000 Autor/in
  1. Drews, Jan |
  2. Baar, Lea-Catharina |
  3. Schmeisl, Theresa |
  4. Bunde, Torsten |
  5. Stang, Axel |
  6. Reese, Tim |
  7. Wagner, Kim Caroline |
  8. Oldhafer, Karl Jürgen |
  9. von Hahn, Thomas |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-10-10
1000 Erschienen in
1000 Quellenangabe
  • 24(1):359
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12876-024-03429-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11468282/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background and aims!#!Relief of cholestasis in hilar cholangiocarcinoma is commonly undertaken in both curative and palliative treatment plans. There are numerous open questions with regard to the ideal biliary drainage strategy - including what constitutes clinical success (CS). In the existing data, curative patients and patients from the Western world are underrepresented.!##!Patients and methods!#!We performed a retrospective analysis of patients with complex malignant hilar obstruction (Bismuth-Corlette II and higher) due to cholangiocarcinoma who underwent biliary drainage at a German referral center between 2010 and 2020. We aimed to define CS and complication rates and directly compare outcomes in curative and palliative patients.!##!Results!#!56 curative and 72 palliative patients underwent biliary drainage. In patients with curative intent, CS was achieved significantly more often regardless of what definition of CS was applied (e.g., total serum bilirubin (TSB) < 2 mg/dl: 66.1% vs. 27.8%, p = < 0.001, > 75% reduction of TSB: 57.1% vs. 29.2%, p = 0.003). This observation held true only when subgroups with the same Bismuth-Corlette stage were compared. Moreover, palliative patients experienced a significantly greater percentage of adverse events (33.3% vs. 12.5%, p = 0.01). Curative intent treatment and TSB at presentation were predictive factors of CS regardless of what definition of CS was applied. The observed CS rates are comparable to published studies involving curative patients, but inferior to reported CS rates in palliative series mostly from Asia.!##!Conclusions!#!Biliary drainage in complex malignant hilar obstruction due to cholangiocarcinoma is more likely to be successful and less likely to cause adverse events in curative patients compared to palliative patients.
1000 Sacherschließung
lokal Klatskin Tumor/complications [MeSH]
lokal Female [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Bile Duct Neoplasms
lokal Aged [MeSH]
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Retrospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Klatskin Tumor
lokal Drainage/methods [MeSH]
lokal Cholestasis/therapy [MeSH]
lokal Palliative Care/methods [MeSH]
lokal Male [MeSH]
lokal Research
lokal Cholestasis/etiology [MeSH]
lokal Germany [MeSH]
lokal Drainage
lokal Bile Duct Neoplasms/therapy [MeSH]
lokal Cholestasis
lokal Cholangiocarcinoma
lokal Bilirubin
lokal Bile Duct Neoplasms/complications [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/RHJld3MsIEphbg==|https://frl.publisso.de/adhoc/uri/QmFhciwgTGVhLUNhdGhhcmluYQ==|https://frl.publisso.de/adhoc/uri/U2NobWVpc2wsIFRoZXJlc2E=|https://frl.publisso.de/adhoc/uri/QnVuZGUsIFRvcnN0ZW4=|https://frl.publisso.de/adhoc/uri/U3RhbmcsIEF4ZWw=|https://frl.publisso.de/adhoc/uri/UmVlc2UsIFRpbQ==|https://frl.publisso.de/adhoc/uri/V2FnbmVyLCBLaW0gQ2Fyb2xpbmU=|https://frl.publisso.de/adhoc/uri/T2xkaGFmZXIsIEthcmwgSsO8cmdlbg==|https://frl.publisso.de/adhoc/uri/dm9uIEhhaG4sIFRob21hcw==
1000 Hinweis
  • DeepGreen-ID: 5953c4184d9342b9bac70e23b5788b42 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6503967.rdf
1000 Erstellt am 2025-02-05T23:44:09.829+0100
1000 Erstellt von 322
1000 beschreibt frl:6503967
1000 Zuletzt bearbeitet 2025-09-12T03:57:40.588+0200
1000 Objekt bearb. Fri Sep 12 03:57:40 CEST 2025
1000 Vgl. frl:6503967
1000 Oai Id
  1. oai:frl.publisso.de:frl:6503967 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source